Market revenue in 2023 | USD 1,292.0 million |
Market revenue in 2030 | USD 1,903.3 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Cmos & cdmos |
Fastest growing segment | CMOs & CDMOS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopharmaceutical Companies, CMOs & CDMOS, Academic And Research Organizations |
Key market players worldwide | Danone SA, Roche Holding AG ADR, Koninklijke DSM NV, Lonza Group Ltd, Novonesis AS ADR, Biocon, BioVectra, TerraVia - Assets, BiOZEEN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial fermentation technology market will help companies and investors design strategic landscapes.
Cmos & cdmos was the largest segment with a revenue share of 42.14% in 2023. Horizon Databook has segmented the Japan microbial fermentation technology market based on biopharmaceutical companies, cmos & cdmos, academic and research organizations covering the revenue growth of each sub-segment from 2018 to 2030.
Japan represents a relatively well-developed healthcare industry in the APAC region with significant involvement of government bodies for active promotion of biotechnology and related industries. The country is witnessing a demographic challenge, as it is considered to have the oldest population in the world. It acts as a catalyst and further drives the demand for biopharmaceutical development to ensure continuous processing.
This, in turn, has resulted in the accelerated adoption of microbial fermentation technology for the production of therapeutics. Players are also involved in the acquisition of companies in Japan to stay competitive in the growing biopharmaceutical market and augment their domestic bioprocessing operations.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan microbial fermentation technology market , including forecasts for subscribers. This country databook contains high-level insights into Japan microbial fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account